Brian Williams

Mr. Williams serves as the Chief Digital Officer, Global Consulting Leader and Vice President, Life Sciences for Cognizant Technology Solutions Corporation (“Cognizant”, NASDAQ: CTSH).  Cognizant is a professional services company that provides consulting, technology and outsourcing services worldwide.  The company is a member of the NASDAQ-100 and S&P 500 indices.  It is also one of the fastest growing Fortune 500 companies with over $16 billion in 2018 revenues. Mr. Williams has dual management and P&L responsibilities within the second largest business unit at Cognizant.  Mr. Williams serves as the Chief Digital Officer for Cognizant Life Sciences.  He leads a team of professionals who develop, test and deploy digital solutions to transform how care is accessed and delivered and how business processes and decision making of biopharmaceutical and medical device and diagnostics manufacturers must adapt to a digitally enabled consumer and clinical environments. Mr. Williams is also responsible for Cognizant’s Life Sciences consulting services where he leads a global team of professionals operating in North America, Europe and Asia who provide management consulting services to the world’s largest biopharmaceutical and medical device and diagnostics manufacturers. In addition to these management obligations, Mr. Williams is responsible for the development of Cognizant Life Sciences’ thought leadership and publications.  As a senior executive of the second largest business unit within Cognizant, Mr. Williams leads the development and execution of the inorganic growth strategy for Cognizant Life Sciences. Prior to joining Cognizant, Mr. Williams spent nearly a decade with Strategy&, the legacy BoozAllenHamilton strategy consulting business of PwC.  As a Managing Director with Strategy&, Mr. Williams led corporate and business unit strategy work for leading medical device and diagnostics companies, managing projects and teams in the US, Europe and Asia.  He was also a founding member of Strategy&/PwC’s “New Entrants” practice which defined the technology enabled transformation of healthcare through multiple industry publications and presentations in the US, Europe and Asia.  As a leader of the “New Entrants” practice, he led healthcare strategy and innovation work for some of the world’s most recognized companies in technology, telecommunications and consumer products in support of financial and managerial investments in healthcare. Previous to Strategy&, Mr. Williams served as an executive at two early stage companies, where he led corporate and business development efforts that resulted in the successful sale of both companies returning 10x and 3x invested capital respectively.  Prior to these management roles, Mr. Williams co-founded two top decile performing private equity funds.  He remains an active angel investor in technology and entertainment with representative investments in 23andme and the Tony-winning play “Come from Away.” Before his business ventures, Mr. Williams served as the lead speechwriter to a former two-term Governor and two-term U.S. Senator for the state of Indiana.  He received his Bachelor of Arts degree from Indiana University, Bloomington, where he was also an A-side player of its Big Ten and National championship rugby club. Back to Board Members